Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 9INDUSTRY 5NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 30Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 18Lung Neoplasms 14Head and Neck Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Ovarian Neoplasms 7Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Salivary Gland Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms, Male 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1

Interventions

Cisplatin 31Brachytherapy 13Radiotherapy 12Paclitaxel 10Taxes 6Gemcitabine 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Topotecan 4Radiotherapy, Intensity-Modulated 4Radiation 4Carboplatin 4Surgical Procedures, Operative 3Fluorouracil 3Cetuximab 3Vinorelbine 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Pemetrexed 2Chemotherapy, Adjuvant 2Celecoxib 2Capecitabine 2Amifostine 2sulfan blue 1oncogene protein E7, Human papillomavirus type 16 1iso-sulfan blue 1ethanethiol 1carfilzomib 1brivanib 1Vindesine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Uterine Cervical Neoplasms × Docetaxel × Clear all
NCT00041093 2018-01-10

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

GOG Foundation

Phase 2 Completed
27 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡